Patents Assigned to INSTITUT CLINIDENT
  • Method of evaluating cancer risk in human
    Patent number: 8993333
    Abstract: Disclosed is a method of providing a risk evaluation and diagnosis of human cancer, by examining the presence, in the volatile fraction of a human saliva sample, of a combination of particulate biochemical volatile organic compounds, which is indicative of an increased risk of developing cancer.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: March 31, 2015
    Assignee: Institut Clinident
    Inventor: Franck Chaubron
  • METHOD OF EVALUATING ORAL CANCER RISK IN HUMAN
    Publication number: 20140065600
    Abstract: A method of providing a risk evaluation and diagnosis of human oral cancer, by examining at the presence in human saliva sample of a combination of particulate nucleic acids from bacteria, virus, as well as human, and/or the presence of particulate biochemical volatile organic compounds, which are indicative of an increased risk of oral cancer.
    Type: Application
    Filed: August 23, 2013
    Publication date: March 6, 2014
    Applicant: Institut Clinident
    Inventor: Franck CHAUBRON
  • METHOD OF EVALUATING ORAL CANCER RISK IN HUMAN
    Publication number: 20110143962
    Abstract: A method of providing a risk evaluation and diagnosis of human oral cancer, by examining at the presence in human saliva sample of a combination of particulate nucleic acids from bacteria, virus, as well as human, and/or the presence of particulate biochemical volatile organic compounds, which are indicative of an increased risk of oral cancer.
    Type: Application
    Filed: August 3, 2009
    Publication date: June 16, 2011
    Applicant: INSTITUT CLINIDENT
    Inventor: Franck Chaubron